Ancora Advisors, LLC Outlook Therapeutics, Inc. Transaction History

Ancora Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.22 - $0.66 $22,000 - $66,000	100,000 Added 454.55%	122,000 $47,000
Q3 2023 Nov 14, 2023	SELL	$0.2 - $1.78 $17,300 - $153,970	-86,500 Reduced 79.72%	22,000 $4,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $1.26 $88,230 - $108,990	86,500 Added 393.18%	108,500 $132,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.01 $20,020 - $44,219	22,000 New	22,000 $22,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.18B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.